The pathway could save CTIX a lot of time because the safety profile of Prurisol can be referenced with its bioequivalent drug, Abacavir. Management should have a pretty good idea about whether P works or not, since the placebo is a sugar pill. As a sponsor, Leo gets a case report of each patient, even though their information is blinded.